ClinicalTrials.Veeva

Menu

The Effect of Post-Cesarean Section Acupressure on the Severity of Pain and First Mobilization Distance

M

Mersin University

Status

Completed

Conditions

Mobilization
Pain

Treatments

Other: Acupressure
Other: Plasebo acupressure

Study type

Interventional

Funder types

Other

Identifiers

NCT05311449
Mersin Universit

Details and patient eligibility

About

This randomized controlled trial evaluates the effect of acupressure application on cesareans' pain and the number of steps in the first mobilization. This study hypothesizes that acupressure reduces pain and improves number of steps.

Full description

Methods: In the study, 64 cesareans will randomly assigned to acupressure and placebo acupressure groups. To the acupressure group (n = 32), an average of 15 minutes will be applied to the LI4 (liver), P6 (pericardium) and the Sanyinjia points on the splenic meridian (SP6) located on the inner side of the lower leg, four fingers above the ankle and behind the tibia. In the placebo acupressure group (n = 32), the points 1.5 cm away from the LI4, P6 and SP6 points (four points in total) will be applied for an average of 15 minutes. The primary outcome of the research is the effect of acupressure on the pain of cesareans. The secondary outcome of the study is to determine the effect of acupressure on the number of steps. The pain will be collected before and 1 minute, 2nd and 4th hour after acupressure and placebo acupressure administration. The number of steps will be collected 4th hour after acupressure and placebo acupressure administration.

Enrollment

64 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Being conscious,
  • The mother tongue is Turkish,
  • To be oriented and cooperative,
  • be between 18-45 years old,
  • To voluntarily agree to participate in the study (signing the Informed Consent Form),
  • Repeated cesarean section,
  • Cesarean section under spinal anesthesia,
  • Not having a risky pregnancy (preeclampsia, gestational diabetes etc.),
  • No health problems of the fetus,
  • To have given birth by cesarean section between 37-40 weeks,
  • To be in the second hour of the postpartum period,
  • Not receiving post-op patient-controlled analgesia,
  • Not to have smoked or used alcohol during pregnancy,
  • No complications in the mother and/or newborn after cesarean section,
  • No sensitivity in the area where acupressure will be applied,
  • Absence of any systemic or psychiatric diagnosis,
  • Absence of active COVID-19 infection.

Exclusion criteria

  • Lack of consciousness,
  • The mother tongue is not Turkish,
  • Not oriented and cooperative,
  • Not to be between the ages of 18-45,
  • Refusal to voluntarily participate in the study (those who did not sign the Informed Consent Form),
  • Normal birth or cesarean delivery under general anesthesia,
  • Cesarean delivery due to the risk of deterioration of maternal or fetal health,
  • Not having had a risky pregnancy (preeclampsia, gestational diabetes, etc.),
  • Not giving birth outside 37-40 weeks and by cesarean section,
  • Not in the second hour of the postpartum period,
  • Receiving post-op patient-controlled analgesia,
  • To have used cigarettes and alcohol during pregnancy,
  • Sensitivity in the area where acupressure will be applied,
  • Presence of any systemic or psychiatric diagnosis,
  • Active COVID-19 infection.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

64 participants in 2 patient groups, including a placebo group

Acupressure Group (experimental)
Experimental group
Description:
The experimental group will be given acupressure.
Treatment:
Other: Acupressure
Placebo Acupressure Group (control)
Placebo Comparator group
Description:
The placebo group will be given placebo acupressure.
Treatment:
Other: Plasebo acupressure

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems